Financial Position and Capital Requirements - The company has approximately $953,750 available outside the trust account to fund working capital requirements, with offering expenses estimated at $600,000[98]. - The company may incur significant costs in pursuit of acquisition plans, and may depend on loans from affiliates to fund operations if necessary[98]. - The company believes that the net proceeds from its initial public offering will be sufficient for its initial business combination, but it may need additional financing if the proceeds are insufficient[135]. - As of December 31, 2025, the company had $296,249 in cash and a working capital deficit of $70,710, indicating a weak cash position[219]. - The company has a working capital deficiency and expects to incur significant costs in pursuit of acquisition plans, raising concerns about capital raising success[219]. Trust Account and Shareholder Rights - The trust account is intended to hold funds pending the completion of the initial business combination or the return of funds to public shareholders if no combination occurs[108]. - Public shareholders will not have voting rights on director appointments prior to the initial business combination[112]. - Shareholders may not have rights to funds from the trust account except under specific circumstances, potentially forcing them to sell shares at a loss[144]. - The trust account may be subject to claims from third parties, potentially reducing the per-share redemption amount below $10.10[149]. - If the company is unable to complete the initial business combination, public shareholders may lose their opportunity for investment appreciation and receive only approximately $10.10 per share[111]. Business Combination Risks and Challenges - If the initial business combination is not completed within the required time, public shareholders may receive only approximately $10.10 per share upon liquidation of the trust account[97]. - The company may incur substantial debt to complete a business combination, which could adversely affect its financial condition and shareholder value[122]. - The company may face challenges in assessing the management capabilities of prospective target businesses, potentially impacting the success of the business combination[119]. - The company may seek acquisition opportunities with early-stage companies or financially unstable businesses, which could introduce numerous operational risks[115]. - The company may not be able to maintain control of a target business post-transaction, affecting operational management[211]. Regulatory and Compliance Issues - Compliance with the Sarbanes-Oxley Act may increase the time and costs associated with completing an acquisition, particularly if the target business is not compliant[138]. - The company is subject to new SEC rules regarding SPACs, which may increase costs and time needed to complete business combinations[222]. - The Inflation Reduction Act of 2022 imposes a 1% U.S. federal excise tax on stock repurchases, which could affect the company if it engages in redemptions post-business combination[229]. - The company is classified as an "emerging growth company" and may take advantage of exemptions from certain disclosure requirements, which could affect the attractiveness of its securities to investors[232]. - The company is also classified as a "smaller reporting company," which allows it to provide only two years of audited financial statements until certain market value or revenue thresholds are met[234]. Shareholder Influence and Governance - Initial shareholders own approximately 25% of the issued and outstanding ordinary shares, which may influence the voting process for amendments[134]. - The company’s initial shareholders may exert substantial influence over actions requiring shareholder votes, potentially affecting corporate governance[166]. - The company’s board of directors will generally serve a three-year term, with current directors continuing until the business combination is completed[167]. - The board includes a majority of independent directors, and there is a compensation committee comprised entirely of independent directors[236]. - The company intends to comply with Nasdaq corporate governance requirements despite being eligible for exemptions[235]. Market and Economic Conditions - Economic and political conditions in the country of operation could significantly impact the company's ability to find and complete a business combination[139]. - The COVID-19 pandemic and other public health crises could adversely affect the company's search for a business combination and the operations of any target business[140]. - There is currently no market for the company's securities, which may affect liquidity and price[142]. - Nasdaq may delist the company's securities if it fails to meet minimum listing standards, including maintaining an average global market capitalization and a minimum of 400 public holders[145]. - The company must ensure its share price remains at least $4.00 per share to comply with Nasdaq's initial listing requirements[145]. Conflicts of Interest - Conflicts of interest may arise as directors and officers may have affiliations with other entities engaged in similar business activities[195]. - The personal financial interests of the sponsor and directors may misalign with public shareholders, especially as the deadline for business combination approaches[207]. - The company has not adopted a policy to prohibit directors and officers from having financial interests in transactions, potentially leading to conflicts[196]. - Founder shares may provide substantial profit to holders even if public shareholders incur losses post-business combination[207]. - The company may pursue business combinations with affiliated entities, although no specific opportunities are currently identified[199].

Financial Performance - Dominari reported a revenue of $123.1 million in 2025, representing a 487% increase from $21.0 million in 2024[3] - Underwriting revenues surged to $79.0 million, a 596% increase compared to $11.4 million in 2024[3] - The company experienced a loss from operations of $55.7 million, an increase of $47.0 million from a loss of $8.7 million in 2024, primarily due to $55.0 million in non-cash stock-based compensation[3] - Other income rose to $42.6 million, an increase of $48.6 million compared to a loss of $6.0 million in 2024, driven by the market value increase of its investment in American Bitcoin Corp.[3] - Non-GAAP adjusted net income (loss) improved to $32.6 million, compared to a net loss of $13.1 million in 2024, reflecting a $45.6 million year-over-year increase[3] - For the year ended December 31, 2025, Dominari Holdings reported a loss from operations of $55,726, compared to a loss of $8,702 in 2024[13] - The adjusted loss from operations for 2025 was $719, significantly improved from an adjusted loss of $7,069 in 2024[13] - The net loss attributable to common stockholders for 2025 was $22,435, compared to a net loss of $14,703 in 2024[13] - Dominari Holdings achieved an adjusted net income attributable to common stockholders of $32,572 in 2025, contrasting with an adjusted net loss of $13,070 in 2024[13] - The basic net income per share for 2025 was $2.28, a recovery from a loss of $2.11 per share in 2024[13] - The weighted average number of shares outstanding increased to 14,285,097 in 2025 from 6,183,397 in 2024[13] Assets and Equity - Liquid assets totaled $94.3 million at the end of 2025, a 248% increase from $27.1 million at the end of 2024[3] - Total assets increased by 140% to $112.9 million, up from $47.1 million in 2024[3] - Total stockholders' equity rose by 74% to $69.4 million, compared to $39.9 million in 2024[3] Dividends - Dominari declared $22.2 million in dividends during the year, marking the first time in its history that dividends were paid[3] Future Outlook - The company expects continued growth in 2026, emphasizing prudent management and exceptional customer service[2] - Dominari Holdings is engaged in wealth management, investment banking, sales and trading, and asset management, aiming to enhance shareholder value through organic growth and opportunities in AI and Data Center sectors[14] - Dominari Securities LLC focuses on capitalizing on emerging trends in financial services to create wealth for stakeholders[15] Risk Management - The company emphasizes the importance of forward-looking statements and the associated risks and uncertainties in its financial outlook[17] - Dominari Holdings maintains a commitment to updating stakeholders as required by law regarding any significant changes in its financial position[17]

Debt and Interest Rates - As of December 31, 2025, the company had $389.5 million in principal debt outstanding with a weighted average interest rate of approximately 12.2%[386] - A 1% increase or decrease in the assumed weighted average interest rate would impact interest expense by approximately $3.9 million per year[386] Foreign Currency Risks - The company is exposed to foreign currency risks from intercompany loans and transactions in currencies other than the functional currency[387] Stock Volatility - The price of the company's common stock has been volatile, posing risks for future equity funding[388] Inflation Impact - Inflation has materially affected the company's business, particularly increasing costs of labor and supplies[389]

Debt and Interest Rates - As of December 31, 2025, the company had $389.5 million in principal debt outstanding with a weighted average interest rate of approximately 12.2%[386] - A 1% increase or decrease in the assumed weighted average interest rate would impact interest expense by approximately $3.9 million per year[386] Foreign Currency Risks - The company is exposed to foreign currency risks from intercompany loans and transactions in currencies other than the functional currency[387] Stock Volatility - The price of the company's common stock has been volatile, posing risks for future equity funding[388] Inflation Impact - Inflation has materially affected the company's business, particularly increasing costs of labor and supplies[389]

Financial Performance - Total revenue for the year ended December 31, 2025, was $16.3 million, an increase from $9.6 million in 2024, primarily driven by ATEC sales of $14.5 million compared to $7.9 million in 2024[166] - The company incurred a net loss of $34.2 million for the year ended December 31, 2025, compared to a net loss of $31.1 million for the year ended December 31, 2024[164] - Operating income (loss) for the Land and Water Resources segment was $(28.1) million in 2025, compared to $(25.0) million in 2024, while the Water Filtration Technology segment reported an operating income of $2.5 million in 2025[164] - Cost of sales for the year ended December 31, 2025, totaled $11.2 million, with a gross margin of 48.4% for ATEC, up from 45.5% in 2024[167] Expenses and Costs - General and administrative expenses increased to $24.2 million in 2025 from $19.7 million in 2024, primarily due to higher legal and consulting fees[168] - Interest expense increased to $8.6 million in 2025 from $7.9 million in 2024, primarily due to increased borrowing under the Lytton Credit Agreement[170] Investments and Acquisitions - The company completed the acquisition of ATEC Water Systems, enhancing its water filtration technology capabilities[151] - The company has established a new special purpose business entity, Mojave Water Infrastructure Company LLC, to finance the Mojave Groundwater Bank project, with estimated capital costs of $1.5 billion[155] - Agreements have been made for the purchase of 21,275 acre-feet per year of water supply, with an estimated market price starting at approximately $850 per acre-foot[154] Cash Flow and Financing Activities - Cash used for operating activities totaled $18.9 million for the year ended December 31, 2025, a decrease from $21.5 million in 2024, primarily due to reduced working capital needs[190] - Cash used for investing activities increased to $12.6 million in 2025 from $1.2 million in 2024, mainly for securing an exclusive option for steel pipeline purchase and other project-related costs[191] - Cash provided by financing activities was $25.4 million for the year ended December 31, 2025, compared to $35.5 million in 2024, with proceeds primarily from share issuance and initial borrowing under the Lytton Credit Agreement[192] - The company entered into the Lytton Credit Agreement, allowing for up to $51 million in unsecured term loans for the Mojave Groundwater Bank construction, with an interest rate of 8% per annum[183] - The company made an initial draw of $15 million from the Lytton Credit Agreement for project expenses in November 2025 and a second draw of $15 million in March 2026[186] - The company expects to meet short-term working capital needs through proceeds from the Lytton Credit Agreement and cash on hand[193] - Long-term capital needs will depend on the progress of the Mojave Groundwater Bank and other development activities, with potential additional capital raises anticipated[194] - The company is evaluating cash requirements and potential financing methods, including equity or debt placements, to minimize dilution for existing shareholders[195] Asset Management and Valuation - The company conducts a quantitative assessment using the present value (discounted cash flow) method to determine the fair value of reporting units with goodwill[202] - In the fourth quarter of 2025, the goodwill of all reporting units in the water and land resources and water filtration technology segments was tested, and it was determined that their fair values were more-likely-than-not greater than their carrying values, indicating no impairment[203] - Long-lived assets, including property, plant, and equipment, are depreciated or amortized over their useful lives, which are based on management's estimates of revenue generation periods[204] Regulatory and Reporting Status - The company is classified as a smaller reporting company and is not required to provide certain market risk disclosures[206]

Financial Results - Massimo Group announced its financial results for Q4 and fiscal year ended December 31, 2025, on March 31, 2026[5]. - A press release detailing the financial results is available as Exhibit 99.1[8]. Company Classification - The company is classified as an emerging growth company under the Securities Act of 1933[4].

Drug Development and Clinical Trials - The company is advancing CAD-1005, a first-in-class selective 12-LOX inhibitor for treating heparin-induced thrombocytopenia (HIT), with a Phase 3 pivotal trial planned following a successful End-of-Phase 2 meeting with the FDA on March 26, 2026[24][40]. - CAD-1005 has received orphan drug designation (ODD) and Fast Track designation from the FDA for the treatment and prevention of HIT, indicating its potential significance in addressing this life-threatening condition[32][41]. - The Phase 1 clinical studies of CAD-1005 demonstrated good tolerability with no serious adverse events reported among 96 healthy subjects[38]. - A Phase 2 pilot study of CAD-1005 showed a high rate of thrombotic events (>75%) in the placebo group compared to 50% in the CAD-1005 group, although it did not meet its primary endpoint of platelet count recovery[39]. - The company plans to secure sufficient financing to commence the pivotal Phase 3 clinical trial for CAD-1005, which is crucial for its development[29][40]. - The company is focused on addressing the underlying pathophysiology of HIT, which existing therapies do not adequately target, potentially positioning CAD-1005 as a transformative treatment[34][36]. - The company is currently focused on the development of CAD-1005, having shifted from its previous focus on tecarfarin[165]. - The company has not yet received the final minutes from its EOP2 meeting with the FDA, which may contain additional comments affecting the Phase 3 trial protocol[176]. - The Phase 2 trial of CAD-1005 in patients with HIT enrolled only 24 patients out of a planned 60 and was terminated early, indicating challenges in patient recruitment[205]. - The company faces significant clinical risks that could impede the advancement of CAD-1005 and its second-generation oral candidates[177]. Financial Position and Funding - The company had an accumulated deficit of approximately $39.0 million as of December 31, 2025, and a net loss of approximately $13.2 million for the fiscal year ended December 31, 2025[160]. - The company expects to incur significant expenses and continued losses from operations for the foreseeable future, indicating a need for additional financing to support its business strategy[160]. - The company plans to raise additional capital to fund its planned clinical trials and support development and commercialization efforts for its product candidates[171]. - The company may need to relinquish significant rights to its technologies or grant licenses on unfavorable terms if it raises funds through partnering or licensing arrangements[160]. - The company anticipates that future capital requirements will be funded through a combination of private and public equity offerings, debt financings, and strategic collaborations[173]. - The company will require additional financing prior to commencing any clinical trial and to meet anticipated cash requirements for at least the next twelve months[171]. - The company faces risks related to its financial position and need for capital, which could adversely affect its ability to continue as a going concern[160]. Regulatory Environment - The company is subject to extensive regulatory requirements, which require significant time and financial resources for compliance and approval processes[103][104]. - The FDA requires two adequate and well-controlled Phase 3 clinical trials to demonstrate drug efficacy, with trials typically involving several hundred to several thousand patients[109]. - The FDA has 60 days to determine if an NDA is accepted for filing, with standard review applications typically reviewed within 10 to 12 months and priority review applications within 6 to 8 months[114]. - Orphan drug designation can provide a seven-year exclusive marketing period in the U.S. for drugs treating rare diseases affecting fewer than 200,000 individuals, along with potential grant funding of up to $500,000 per year for four years[121]. - Accelerated approval allows for early drug approval based on surrogate or intermediate clinical endpoints, significantly shortening the time required for clinical trials[124]. - The cost of preparing and submitting an NDA is substantial, with manufacturers potentially assessed up to five program fees for a fiscal year for prescription drug products identified in a single approved NDA[113]. - The FDA may impose sanctions or discontinue a clinical trial if it believes the trial is not compliant with requirements or poses unacceptable risks to patients[110]. - The company has never submitted a New Drug Application (NDA) to the FDA and relies on third-party contract research organizations (CROs) for assistance in the approval process[214]. Market Potential and Competition - The estimated peak annual market revenue potential for CAD-1005 in patients with HIT is approximately $825 million, while the combined peak annual U.S. market revenue potential for tecarfarin and frunexian is estimated at $2 billion[96][97]. - The company faces substantial competition from major pharmaceutical companies and other entities in the development and commercialization of its product candidates[91][95]. - The commercial success of product candidates will depend on obtaining favorable labeling from regulatory authorities, which may not align with the company's expectations[206]. - The commercial success of the company's product candidates will depend on market acceptance by physicians, patients, and healthcare payors, which is influenced by factors such as efficacy, safety, and pricing[211]. Manufacturing and Supply Chain - The company has completed the manufacturing of tecarfarin drug product in accordance with cGMP and has contracts with third-party CDMOs for development and supply, but lacks long-term supply agreements[87][88]. - The company does not have any long-term supply agreements or commercialization partnerships with manufacturers for its product candidates, which may expose it to risks in production and distribution[218]. - The company anticipates that if approved by the FDA, it will be able to enter into agreements with third parties for the manufacturing and distribution of its product candidates[220]. - The company faces risks related to supply disruptions, regulatory compliance, and loss of key manufacturing partners that could delay product development and commercialization[223]. Intellectual Property and Agreements - The company acquired the Veralox assets, including CAD-1005 and related compounds, on December 10, 2025, enhancing its pipeline and intellectual property portfolio[26][27]. - The company has acquired intellectual property from Veralox and eXIthera, including U.S. and foreign patents for 12-LOX inhibitors and Factor XIa inhibitors, with various expiration dates for these patents[98][100]. - The company entered into a Veralox Purchase Agreement for $200,000 in cash, with contingent milestone payments not exceeding $15 million based on clinical and regulatory achievements[75]. - The eXIthera Purchase Agreement involved acquiring assets for $50,000 in transaction costs and up to $15 million in milestone payments based on clinical and regulatory events[83][84]. - The company is obligated to pay eXIthera a 2% royalty on annual net sales of pharmaceutical products containing compounds from the eXIthera Purchase Agreement, payable from the first commercial sale until the expiration of patent claims[84]. Employee and Corporate Structure - The company has five full-time employees and approximately thirty-five consultants and contractors as of March 27, 2025[146]. - The corporate headquarters are leased with a monthly rent of $2,346, under a lease agreement that commenced on November 1, 2025[148]. - The company qualifies as an "emerging growth company," allowing it to take advantage of reduced reporting requirements until certain revenue or debt thresholds are met[152]. - The company has opted for an extended transition period to comply with new accounting standards, potentially delaying compliance compared to other public companies[153].

Revenue Performance - For the fiscal year 2025, Professional Diversity Network, Inc. generated approximately $6.55 million in revenue, reflecting a 2.7% decline from the prior year[2]. - TalentAlly Network's revenue for Q4 2025 was approximately $787,000, a decrease of 21.5% from approximately $1,002,000 in Q4 2024[4]. - NAPW Network's revenue for the year ended December 31, 2025, was approximately $343,000, a decrease of 20.0% from approximately $429,000 in 2024[10]. - RemoteMore's revenue increased to approximately $802,000 in Q4 2025, representing a growth of 52.5% compared to approximately $526,000 in Q4 2024[6]. - Contracted software development revenue grew significantly to approximately $2.73 million in 2025, up 49.0% from approximately $1.83 million in 2024[5]. Financial Loss and Expenses - The company incurred a net loss of approximately $6.51 million from continuing operations for the year ended December 31, 2025, an increase of 150.9% compared to a net loss of approximately $2.60 million in 2024[12]. - General and administrative expenses increased by approximately $3.67 million, or 103.9%, to approximately $7.21 million during the year ended December 31, 2025[11]. Assets and Liabilities - Total current assets decreased to approximately $2.56 million as of December 31, 2025, down from approximately $3.23 million in 2024[14]. - The total liabilities increased to approximately $6.69 million as of December 31, 2025, compared to approximately $3.14 million in 2024[14]. Company Strategy and Operations - The company invested approximately $6.93 million in copyright-related assets during fiscal year 2025 as part of its strategy to expand into intellectual property initiatives[5]. - Professional Diversity Network, Inc. operates online and in-person networks for diverse professionals, including subsidiaries like the National Association of Professional Women (NAPW) and the International Association of Women (IAW)[21]. - The company aims to be a leader in business diversity recruiting, networking, and professional development for women, minorities, veterans, LGBTQ+, and disabled persons globally[21]. Risk Factors and Disclosures - The forward-looking statements in the press release are based on current expectations and involve risks and uncertainties that could lead to actual results differing materially[22]. - The company has disclosed risk factors in its most recently filed Annual Report on Form 10-K and subsequent filings with the SEC[22]. - The financial information and reports are available on the company's website under the "Investor Relations" section[22].

Strategic Transformation and Growth Initiatives - In fiscal year 2025, the Company initiated a strategic transformation to expand into Web3.0, copyrights, digital assets, and real-world asset platforms, aiming to diversify revenue streams and integrate emerging technologies [21]. - The Company’s strategy includes pursuing acquisition opportunities to increase returns to shareholders, such as the purchase of Expo Experts LLC and an additional equity stake in RemoteMore USA [33]. - The company entered into a partnership with AI Geo in 2024 to leverage AI technology for enhancing job seeker engagement through a mock interview platform [47]. - The company has incorporated AI technologies into its platform since 2024, which presents unique risks, including potential inaccuracies and regulatory scrutiny [144]. - The company established a wholly owned subsidiary in Tokyo, Japan, in 2025, which is currently not a material contributor to revenues and remains in development [22]. - The company has established a wholly owned subsidiary in Tokyo, Japan, to assist with business development activities related to Web3.0 initiatives [65]. Revenue and Financial Performance - Revenues decreased from $6.7 million in 2024 to $6.5 million in 2025, while costs and expenses increased from $9.1 million in 2024 to $13.0 million in 2025 [89]. - The company recorded a net loss from continuing operations before interest and tax of approximately $6.4 million for the year ended December 31, 2025, compared to a loss of $2.4 million for the year ended December 31, 2024 [89]. - Total revenues decreased by approximately $184,000, or 2.7%, from approximately $6,731,000 in 2024 to approximately $6,547,000 in 2025 [209]. - Recruitment services revenue declined by approximately $978,000, or 22.1%, from $4,434,000 in 2024 to $3,456,000 in 2025 [209]. - TalentAlly Network generated approximately $3,477,000 in revenues in 2025, a decrease of approximately $995,000, or 22.2%, from $4,472,000 in 2024 [210]. - NAPW Network revenues were approximately $343,000 in 2025, a decrease of approximately $86,000, or 20.0%, from $429,000 in 2024 [211]. - RemoteMore revenue for the year ended December 31, 2025, was approximately $2,727,000, an increase of approximately $897,000 or 49.0% compared to $1,830,000 in the prior year [212]. Market and Demographic Insights - The U.S. population reached approximately 341.1 million as of January 1, 2025, reflecting a 0.78% increase from the previous year, with significant demographic shifts expected by 2060 [39]. - The buying power of minority groups grew significantly, with Asian-American buying power increasing by 111% to $1.3 trillion and Hispanic buying power growing by 87% to $1.9 trillion between 2010 and 2020 [39]. - The labor force participation rate for women was 57.5% in January 2025, slightly below the pre-pandemic rate of 58.0% in February 2020 [39]. Diversity and Inclusion - As of December 31, 2025, the Board of Directors comprised 29% female directors and 86% non-white directors, reflecting the Company’s commitment to diversity [27]. - The NAPW Network membership base is diverse, including members from small and large corporations, entrepreneurs, and business owners, which is considered a key component of its value [74]. - The NAPW Network offers upgraded memberships that include additional promotional tools and mentorship opportunities, contributing to member retention and acquisition [59]. Challenges and Risks - The company faces significant competition from established online professional networking companies, which may adversely affect its sales and operational results [90]. - The market for digital assets and intellectual property investments is highly competitive and subject to significant market volatility and regulatory uncertainty [95]. - The company may incur significant liabilities if it fails to comply with privacy-related laws, which could adversely affect its business [80]. - The company has limited operating experience in new areas such as digital assets and may not generate meaningful revenue from these initiatives [95]. - The existing global economic environment has negatively affected demand for services, with potential impacts on revenue if economic conditions worsen [127]. - The company faces risks associated with remote work, as many contractors use personal devices that may lack adequate security measures, exposing the business to cyber-attack risks [119]. - The company's growth strategy may be jeopardized by changing social trends, including increased privacy concerns and potential shifts in diversity hiring practices, which could adversely affect revenues [128]. - A recent Supreme Court ruling on race-conscious admissions may influence corporate diversity initiatives, potentially impacting the market for the company's services [130]. Costs and Expenses - Total costs and expenses increased to approximately $12,999,000 for the year ended December 31, 2025, representing a $3,863,000 or 42.3% increase from $9,136,000 in 2024 [213]. - General and administrative expenses surged by approximately $3,672,000 or 103.9%, largely due to professional consultancy services for planned expansion into new business areas [215]. - Costs and expenses related to RemoteMore increased by approximately $906,000 or 42.3%, primarily due to higher contractor costs and consulting service expenses [219]. - Costs and expenses related to the TalentAlly Network decreased by approximately $824,000 or 18.3%, mainly due to reductions in sales and marketing expenses [217]. - Costs and expenses related to the NAPW Network decreased by approximately $98,000 or 17.1%, driven by lower payroll-related costs and reduced administrative expenses [218]. Intellectual Property and Compliance - The company recorded a $450,000 litigation settlement reserve in 2020 and an additional $250,000 in 2025 related to ongoing legal proceedings [179]. - The protection of intellectual property is critical, and failure to enforce these rights could materially harm the company's business and operating results [132]. - The regulatory environment regarding data privacy is evolving, and any failure to comply with these regulations could lead to enforcement actions and loss of customer trust [136]. - Legal and regulatory frameworks governing AI are rapidly changing, which may impose new obligations and increase compliance costs for the company [147]. Stock and Shareholder Information - The closing stock price of the company's Common Stock ranged from $1.02 to $9.01 during the fiscal year of 2025, indicating significant volatility [151]. - The company has a shelf registration statement allowing for the issuance of shares up to an aggregate amount of $45,000,000, which may adversely affect the market price of its Common Stock [153]. - In September 2025, the company entered into a Securities Purchase Agreement with Streeterville Capital, LLC, agreeing to issue shares for an aggregate purchase price of up to $20,000,000 [154]. - The Board of Directors adopted the 2023 Equity Compensation Plan, initially reserving 750,000 shares of Common Stock, which was later adjusted to 75,000 shares after a 10-for-1 reverse stock split [155]. - The company does not intend to declare or pay any cash dividends in the foreseeable future, opting to retain earnings for business development [161]. - The CFL Group holds a participation right to maintain its ownership interest up to 54.64% of the outstanding Common Stock, potentially limiting the company's ability to raise funds [162].

Revenue Performance - Total revenue decreased by $37.5 million, or 34.3%, from $109.3 million in 2024 to $71.8 million in 2025[279] - Revenue from UTVs, ATVs, and e-bikes decreased by $35.1 million, or 33.3%, from $105.6 million in 2024 to $70.4 million in 2025[282] - Revenue from sales of Pontoon Boats decreased by $2.3 million, or 62.6%, from $3.8 million in 2024 to $1.4 million in 2025[285] - Total revenue decreased by 34.3% from $76.9 million in 2024 to $48.3 million in 2025, while total cost of revenue decreased by $28.3 million, or 36.9%[288] Profitability - Gross profit for 2025 was $26.9 million, representing 37.5% of sales, compared to $32.5 million, or 29.7% of sales, in 2024[278] - Gross profit for 2025 was $23.5 million, down from $32.5 million in 2024, but gross margin expanded by 280 basis points from 29.7% to 32.7%[291] - Income from operations decreased by $3.1 million, or 60.8%, from $5.0 million in 2024 to $2.0 million in 2025[278] - Net income decreased by $252,568, or 14.3%, from $1.8 million in 2024 to $1.5 million in 2025[278] - Net income for 2025 was $1.5 million, down from $1.8 million in 2024, attributed to fluctuations in revenues and gross profit[306] - Net income decreased by $0.3 million in fiscal 2025 compared to fiscal 2024[312] - The gross margin for Pontoon Boats improved from 9.3% to 20.1%, reflecting a shift towards more profitable Direct-to-Consumer sales channels[293] Expenses Management - Operating expenses decreased by $2.4 million, or 8.9%, from $27.4 million in 2024 to $25.0 million in 2025[278] - Research and development expenses increased by $1.7 million, or 508.2%, from $343,493 in 2024 to $2.1 million in 2025[278] - Selling expenses decreased by $2.4 million, or 24.5%, from $9.8 million in 2024 to $7.4 million in 2025, primarily due to lower shipping and handling fees[294] - General and administrative expenses decreased by $1.0 million, or 6.2%, from $16.5 million in 2024 to $15.5 million in 2025[295] Cash Flow and Capital Management - Net cash used in operating activities was approximately $0.1 million in 2025, a decrease of $6.8 million compared to $6.7 million in 2024[308] - Net cash used in investing activities increased to approximately $0.7 million in 2025 from $0.2 million in 2024, primarily due to the purchase of crypto assets[308] - Net cash used in financing activities was approximately $3.6 million in 2025, compared to a net cash inflow of approximately $3.0 million in 2024[309] - The company plans to explore raising additional capital through stock issuance to meet future cash needs[314] Balance Sheet Highlights - Current assets were approximately $39.8 million as of December 31, 2025, with cash and cash equivalents of approximately $5.7 million[313] - Positive working capital was reported at $17.6 million as of December 31, 2025[313] - Accounts payable decreased by approximately $1.8 million in fiscal 2025, compared to a decrease of approximately $0.8 million in fiscal 2024[312] - Tax payable increased by approximately $2.5 million in fiscal 2025, compared to a decrease of approximately $1.0 million in fiscal 2024[312] - Prepaid and other current assets increased by approximately $1.3 million in fiscal 2025, compared to an increase of $0.6 million in fiscal 2024[312] - Capital expenditures were approximately $65,361 in fiscal 2025, significantly lower than $387,876 in fiscal 2024[315] - Lease commitments totaled $8,645,072 as of December 31, 2025, with $2,532,671 due within one year[316] - Non-cash items amounted to approximately $1.0 million in fiscal 2025, down from approximately $6.2 million in fiscal 2024[312] Strategic Initiatives - The company strategically tightened wholesale shipments to assist major retail partners in managing inventory levels[279] - The company aims to preserve premium brand pricing while preparing for the rollout of a higher-margin 2026 vehicle lineup[284]